| Lee, Jung-Hee |
| Recruiting | N/A | 7 | RoW | TIRA catheter, CA10 and ohter 3 models | Tau Pnu Medical Co., Ltd. | Hypertrophic Obstructive Cardiomyopathy | 04/26 | 08/26 | | |
DOSE, NCT05702060: Randomized Comparison of Radiation Exposure to Operators in Coronary Intervention Between Right Radial and Left DRA |
|
|
| Recruiting | N/A | 1010 | RoW | Radial Artery Puncture Method for Coronary Angiography and Intervention | Yonsei University, Myung In Pharm | Radiation Exposure | 12/25 | 12/25 | | |
| Kim, Min Chan |
NCT05664555: Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study) |
|
|
| Completed | 4 | 144 | RoW | Fluorescein Sodium | Seoul National University Bundang Hospital | Retinal Disease | 03/24 | 03/24 | | |
| Active, not recruiting | 3 | 245 | Europe, Canada, Japan, US, RoW | Ponatinib, Iclusig, Imatinib, Gleevec, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone | Takeda | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) | 08/22 | 07/27 | | |
|
|
| Active, not recruiting | 3 | 502 | Europe, Canada, Japan, US, RoW | tisotumab vedotin, TIVDAK, topotecan, vinorelbine, gemcitabine, irinotecan, pemetrexed | Seagen Inc., Genmab | Cervical Cancer | 07/23 | 08/25 | | |
| Active, not recruiting | 3 | 615 | Europe, Canada, US, RoW | Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo | CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd | Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms | 09/25 | 08/27 | | |
NRG-GY019, NCT04095364: Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
|
|
| Recruiting | 3 | 450 | Europe, Canada, US, RoW | Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Imaging Technique, Diagnostic Imaging Technique, Image Type, Imaging, Imaging (procedure), imaging procedure, Imaging Procedures, imaging type, IMAGING_METHOD, imaging_type, Medical Imaging, Type of imaging, Letrozole, CGS 20267, Femara, Fempro, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat | NRG Oncology, National Cancer Institute (NCI) | Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8, Stage III Fallopian Tube Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8 | 02/27 | 02/28 | | |
CRESCENDO, NCT06072131: To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL |
|
|
| Recruiting | 3 | 504 | Europe, US, RoW | Belinostat Injection, Beleodaq®, Pralatrexate Injection, Folotyn®, CHOP, Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone, COP, Cyclophosphamide, Oncovin (vincristine), and Prednisone | Acrotech Biopharma Inc. | Peripheral T Cell Lymphoma | 07/30 | 11/30 | | |
NCT04696120: Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial |
|
|
| Not yet recruiting | 2 | 200 | RoW | Apixaban, apixaban 5mg or 2.5mg bid, Placebo, placebo bid | Korea University Guro Hospital, Dt&Sanomedics | Heart Failure, Sinus Rhythm, Cerebrovascular Disease | 08/22 | 02/23 | | |
NCT05665023: Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma |
|
|
| Recruiting | 2 | 37 | RoW | Bevacizumab + modified FOLFIRINOX | Yonsei University | Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | 02/24 | 02/25 | | |
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma |
|
|
| Active, not recruiting | 2 | 134 | US, RoW | SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo | Coherus Biosciences, Inc. | Hepatocellular Carcinoma | 05/25 | 05/26 | | |
NCT04903873: A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 110 | US, RoW | EU101 | Eutilex | Solid Tumor, Renal Cell Cancer Metastatic, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Prostate Cancer | 09/25 | 12/25 | | |
| Recruiting | 1/2 | 220 | Europe, Canada, US, RoW | BOLD-100 in combination with FOLFOX Chemotherapy (Dose Expansion), BOLD-100 in combination with FOLFOX Chemotherapy (Dose Escalation) | Bold Therapeutics, Inc., Bold Therapeutics, Inc. (Bold) | Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, Cholangiocarcinoma | 06/26 | 09/26 | | |
NCT05113693: Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393 |
|
|
| Completed | 1 | 33 | RoW | CKD-393, CKD-501, D759, H053 | Chong Kun Dang Pharmaceutical | Type 2 Diabetes | 12/21 | 12/21 | | |
NCT05113849: Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19) |
|
|
| Recruiting | 1 | 40 | RoW | IN-B009 (Low-dose), IN-B009 (High-dose) | HK inno.N Corporation | COVID-19 | 02/23 | 02/23 | | |
EARLY-UNLOAD, NCT04775472: Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation |
|
|
| Completed | N/A | 116 | RoW | Early left atrial septostomy within 12 hours after VA-ECMO implantation, Selective left atrial septostomy | Chonnam National University Hospital | Cardiogenic Shock | 03/22 | 10/23 | | |
| Completed | N/A | 70 | US | Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools., SPiN Thoracic Navigation System™, Veran System | Veran Medical Technologies | Lung Lesion(s) Requiring Evaluation, Pulmonary Metastasis, Pulmonary Nodule, Solitary, Peripheral Lung Lesions | 01/23 | 02/23 | | |
VISION, NCT04151615: VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma |
|
|
| Completed | N/A | 203 | RoW | | Boryung Pharmaceutical Co., Ltd | Multiple Myeloma | 01/23 | 01/23 | | |
NCT04853563: Comparison of PEEP in Acute Decompensated Heart Failure |
|
|
| Recruiting | N/A | 120 | RoW | PEEP | Asan Medical Center | Heart Decompensation, Mechanical Ventilation Pressure High | 07/23 | 04/24 | | |
NCT03763604: Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer |
|
|
| Approved for marketing | N/A | | Europe, Canada, RoW | Abemaciclib, LY2835219 | Eli Lilly and Company | Metastatic Breast Cancer | | | | |
| Recruiting | N/A | 280 | RoW | Vi-Sealer, Ligasure, Other AHD | Hyun Park | Benign Gynecologic Neoplasm | 12/24 | 10/25 | | |
NCT04322851: B-line by Lung US in Patients With Acute Decompensated Heart Failure |
|
|
| Recruiting | N/A | 300 | RoW | Lung ultrasound | Asan Medical Center | Heart Failure | 03/24 | 03/24 | | |
FRAME-AMI3, NCT06227754: OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts |
|
|
| Recruiting | N/A | 1500 | RoW | Angiography-guided PCI group, Optical coherence tomography-guided PCI group | Chonnam National University Hospital, Samsung Medical Center | ST Elevation Myocardial Infarction, Myocardial Infarction | 12/28 | 12/29 | | |
ORIGO, NCT06597175: Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy |
|
|
| Recruiting | N/A | 300 | RoW | ORIGO | Olive Healthcare | Breast Cancer, Breast Tumor, Mammary Carcinoma, Human | 10/24 | 10/24 | | |
NCT06537752: A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients |
|
|
| Recruiting | N/A | 1052 | RoW | | Boryung Pharmaceutical Co., Ltd | Breast Cancer | 10/26 | 10/26 | | |
| Terminated | N/A | 316 | RoW | Immediate coronary angiography within 2 hours after randomization, Delayed coronary angiography after stabilization of heart failure | Chonnam National University Hospital | Heart Failure, Acute Coronary Syndrome | 03/24 | 03/24 | | |
NCT04968808: Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) |
|
|
| Recruiting | N/A | 676 | RoW | Staged in-hospital complete revascularization, Immediate complete revascularization | Chonnam National University Hospital | Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis, Multi Vessel Coronary Artery Disease | 08/24 | 08/25 | | |
NCT05493904: PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX) |
|
|
| Recruiting | N/A | 320 | RoW | OCT-guided PCI, Angiography-guided PCI, Drug-eluting stent | Chonnam National University Hospital, Abbott Medical Devices | Coronary Artery Disease, Angina Pectoris | 08/24 | 12/26 | | |
NCT06049914: Combined Exercise and Nutrition Intervention for Possible Sarcopenia Among Older Adults in Primary Care |
|
|
| Recruiting | N/A | 94 | RoW | Experimental group | Kyunghee University Medical Center | Sarcopenia | 12/24 | 12/24 | | |
| Not yet recruiting | N/A | 294 | NA | share decision aids | National Cancer Center, Korea, Seoul National University Hospital, Seoul National University Bundang Hospital, SMG-SNU Boramae Medical Center, Nowon Eulji Medical Center, Hanyang University | Thyroid Cancer, Papillary Thyroid Carcinoma | 12/27 | 12/27 | | |
| Active, not recruiting | N/A | 994 | RoW | Staged in-hospital or Immediate complete revascularization | Chonnam National University Hospital | Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis | 02/25 | 12/29 | | |
NCT05276258: Cryoablation of Intercostal Nerves for Post-Operative Pain Management in Opioid-Tolerant Patients |
|
|
| Enrolling by invitation | N/A | 75 | US | cryoSPHERE Ablation, cryoSPHERE, Bupivacaine, liposomal bupivacaine, Exparel | The Methodist Hospital Research Institute | Pain, Pain, Postoperative | 03/25 | 09/25 | | |
NCT05585411: PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial |
|
|
| Recruiting | N/A | 450 | RoW | Left bundle branch area pacing, Right ventricular pacing | Yonsei University | Bradyarrhythmia, Atrioventricular Block, Left Bundle Branch Area Pacing | 11/26 | 11/26 | | |
PACE-SHOCK, NCT06078436: Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF |
|
|
| Recruiting | N/A | 160 | RoW | Pulmonary artery catheter, Swan-Ganz catheter | Min-Seok Kim | Heart Failure With Reduced Ejection Fraction, Cardiogenic Shock | 09/27 | 03/28 | | |
| Active, not recruiting | N/A | 500 | Europe, US, RoW | LINX Reflux Management System, LINX | Ethicon Endo-Surgery | Gastroesophageal Reflux | 07/32 | 07/32 | | |
SOROCk, NCT04251052: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer |
|
|
| Recruiting | N/A | 2262 | Canada, US, RoW | Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, bilateral salpingo-oophorectomy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, transvaginal sonography, TVS, TVU, Ultrasound Imaging, 2-Dimensional Grayscale Ultrasound Imaging, 2-Dimensional Ultrasound Imaging, 2D-US, Ultrasonography, Ultrasound, Ultrasound Test, Ultrasound, Medical, US | NRG Oncology, National Cancer Institute (NCI) | Ovarian Carcinoma | 06/36 | 06/37 | | |
NCT04174157: Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) |
|
|
| Recruiting | N/A | 700 | Europe, Japan, US, RoW | Prospective observational registry, Zolgensma | Novartis Pharmaceuticals, United BioSource, LLC | Spinal Muscular Atrophy (SMA) | 06/38 | 06/38 | | |
| Recruiting | N/A | 3000 | RoW | | Kangbuk Samsung Hospital | Ovarian Neoplasms | 12/40 | 12/40 | | |
| Active, not recruiting | N/A | 4972 | RoW | Colectomy for colon cancer | Seoul National University Hospital | Colorectal Cancer | 09/21 | 12/21 | | |
| Lee, Dong Young |
| Recruiting | 3 | 1200 | Europe, Canada, Japan, US, RoW | Remternetug, LY3372993, Placebo | Eli Lilly and Company | Alzheimer's Disease | 04/29 | 10/30 | | |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
NCT05559983: Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults |
|
|
| Recruiting | 1 | 150 | RoW | OSP:rTTHc Cholera Conjugate Vaccine Cohort A, OSP:rTTHc Cholera Conjugate Vaccine with Aluminum phosphate adjuvant Cohort A, Placebo Cohort A, OSP:rTTHc Cholera Conjugate Vaccine Cohort B, OSP:rTTHc Cholera Conjugate Vaccine with Aluminum phosphate adjuvant Cohort B, Placebo Cohort B, OSP:rTTHc Cholera Conjugate Vaccine Cohort C, OSP:rTTHc Cholera Conjugate Vaccine with Aluminum phosphate adjuvant Cohort C, Placebo Cohort C | International Vaccine Institute, EuBiologics Co.,Ltd, Massachusetts General Hospital | Cholera Vaccination Reaction | 07/23 | 01/24 | | |
NCT04738253: Correlation Between Ultrasonography Finding and Shoulder Range of Motion in Stroke Patients |
|
|
| Recruiting | N/A | 50 | RoW | Ultrasonography | Yeungnam University Hospital | Cerebral Stroke, Frozen Shoulder | 12/21 | 12/21 | | |
KBASE, NCT02137460: Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease |
|
|
| Completed | N/A | 721 | RoW | | Seoul National University Hospital, Ministry of Science and ICT, Republic of Korea | Alzheimer's Disease, Mild Cognitive Impairment | 12/22 | 01/23 | | |
NCT04538807: EMG Finding According to the Type of Lumbar Disc Herniation |
|
|
| Recruiting | N/A | 74 | RoW | electromyography | Yeungnam University Hospital | Intervertebral Disc Displacement, Electromyography | 12/22 | 12/22 | | |
NCT05262452: Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer |
|
|
| Recruiting | N/A | 60 | RoW | ALPIUS 900, an ultrasound-guided high intensity focused ultrasound system, FOLFIRINOX regimen | Seoul National University Hospital, Focused Ultrasound Foundation, Synex Consulting Ltd | Pancreatic Cancer Non-resectable, Chemotherapy Effect, Ultrasound Therapy | 03/23 | 12/24 | | |
NCT05690451: Non-contrast Abbreviated MRI for Secondary Surveillance of HCC |
|
|
| Completed | N/A | 210 | RoW | non-contrast abbreviated MRI, Contrast enhanced liver CT | Seoul National University Hospital | Hepatocellular Carcinoma | 06/24 | 06/24 | | |
NCT04736888: Effectiveness of Extended Reality CPR Training Methods |
|
|
| Completed | N/A | 154 | RoW | extended-reality CPR training, conventional CPR training | Seoul National University Hospital, Seoul National University Bundang Hospital, Children's Hospital Los Angeles, Royal Manchester Children's Hospital | Basic Cardiac Life Support, Virtual Reality | 09/24 | 09/24 | | |
KBASE2, NCT05138263: Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 |
|
|
| Recruiting | N/A | 640 | RoW | | Seoul National University Hospital, National Institute on Aging (NIA) | Alzheimer Disease, Mild Cognitive Impairment | 06/26 | 06/26 | | |
| Lee, Kwan Woo |
| Active, not recruiting | 3 | 197 | RoW | besifovir 150mg, tenofovir 300mg | IlDong Pharmaceutical Co Ltd | Chronic Hepatitis B | 02/16 | 01/23 | | |
NCT04679350: Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia |
|
|
| Terminated | 2 | 1 | RoW | hzVSF-v13, a humanized monoclonal antibody (mAb), Placebo (Normal saline solution), 0.9% Normal saline | ImmuneMed, Inc. | COVID-19 | 11/22 | 12/22 | | |
| Recruiting | N/A | 200 | RoW | Observation only | Kaohsiung Medical University Chung-Ho Memorial Hospital, Chang Gung Memorial Hospital, National Taiwan University Hospital, National Cheng-Kung University Hospital, Chi Mei Medical Hospital, China Medical University, China, Mackay Memorial Hospital, Taipei Veterans General Hospital, Taiwan, Changhua Christian Hospital, Pusan National University Hospital, Asan Medical Center, Korea University, Inje University, Korea University Guro Hospital, Kyungpook National University Hospital, Seoul National University Hospital, Severance Hospital, Samsung Medical Center, Seoul National University Bundang Hospital, Soon Chun Hyang University, Seoul St. Mary's Hospital, Gachon University Gil Medical Center, Dong-A University Hospital, Gangnam Severance Hospital | Liver Fibroses, HepatoCellular Carcinoma, Cryoglobulinemia, Metabolic Disease, Diabetes Mellitus | 09/22 | 09/22 | | |
NCT03142152: The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR |
|
|
| Recruiting | N/A | 300 | Europe, US | Carillon Mitral Contour System, Carillon, Percutaneous mitral valve repair, Guideline Directed Heart Failure Medication | Cardiac Dimensions, Inc. | Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases | 12/26 | 12/30 | | |
| Recruiting | N/A | 1350 | RoW | Percutaneous coronary intervention | Samsung Medical Center, Seoul St. Mary's Hospital, Seoul National University Bundang Hospital, Korea University Ansan Hospital, Chonnam National University Hospital, Chung-Ang University Gwangmyeong Hospital, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gyeongsang National University Hospital, Uijeongbu St. Mary Hospital, Keimyung University Dongsan Medical Center, Inha University Hospital, Chungbuk National University, Wonju Severance Christian Hospital, SMG-SNU Boramae Medical Center, Kangbuk Samsung Hospital, Sungkyunkwan University, Ewha Womans University, Korea University Guro Hospital | Coronary Artery Disease | 07/27 | 12/28 | | |
| Sagong, Min |
PROUD, NCT05666804: Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy |
|
|
| Recruiting | 3 | 160 | RoW | Brolucizumab 6mg, Beovu | Novartis Pharmaceuticals | Macular Polypoidal Choroidal Vasculopathy (PCV) | 09/25 | 09/25 | | |
EB-203-201, NCT06487039: Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration |
|
|
| Recruiting | 2 | 50 | RoW | EB-203 | EyebioKorea, Inc. | Neovascular Age-related Macular Degeneration (nAMD) | 08/25 | 01/26 | | |
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema |
|
|
| Recruiting | 2 | 150 | Japan, US, RoW | KHK4951, Aflibercept Injection | Kyowa Kirin Co., Ltd. | Diabetic Macular Edema (DME) | 11/25 | 12/25 | | |
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration |
|
|
| Recruiting | 2 | 180 | Japan, US, RoW | KHK4951, Aflibercept Injection | Kyowa Kirin Co., Ltd. | Neovascular Age-Related Macular Degeneration (nAMD) | 11/25 | 12/25 | | |
PMC403-A01, NCT05953012: Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration |
|
|
| Recruiting | 1 | 36 | RoW | PMC-403, Monotherapy | PharmAbcine, C&R Research, Inc. | Neovascular Age-related Macular Degeneration | 05/24 | 10/25 | | |
| Jung, Sung Mee |
DREAMM-10, NCT06679101: A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM) |
|
|
| Recruiting | 3 | 520 | RoW | Belantamab mafodotin, Lenalidomide, Dexamethasone, Daratumumab | GlaxoSmithKline | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 12/30 | 04/32 | | |
NCT05590572: A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma |
|
|
| Not yet recruiting | 1/2 | 148 | RoW | Sulfatinib, Etoposide, Isophosphamide | Second Affiliated Hospital, School of Medicine, Zhejiang University, Chonnam National University, Peking University People's Hospital, Qilu Hospital of Shandong University, Ruijin Hospital, Shanghai Jiao Tong University Affiliated Sixth People's Hospital | Osteosarcoma | 12/26 | 12/27 | | |
NCT04190082: The Effect of Bispectral Index Monitoring on Recovery From Deep Sedation |
|
|
| Terminated | N/A | 12 | RoW | | Yeungnam University College of Medicine | Cerebral Palsy | 12/22 | 12/22 | | |
NCT05505123: Sevoflurane and Propofol for Botulinum Toxin Injection |
|
|
| Withdrawn | N/A | 60 | RoW | Sevoflurane, sevoflurane group, Propofol, propofol group | Yeungnam University College of Medicine | Cerebral Palsy | 12/22 | 12/22 | | |
| Jang, Byung Ik |
| Recruiting | 3 | 778 | Europe, Canada, Japan, US, RoW | Mirikizumab, LY3074828 | Eli Lilly and Company | Crohn's Disease | 11/24 | 12/26 | | |
NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis |
|
|
| Recruiting | 2 | 207 | Europe, Canada, Japan, US, RoW | TAK-279, Zasocitinib, Placebo | Takeda | Ulcerative Colitis | 09/26 | 08/27 | | |
| Kim, Woong |
| Active, not recruiting | 4 | 2018 | RoW | Tailored antithrombotic strategy, Conventional antithrombotic strategy | Duk-Woo Park, MD, CardioVascular Research Foundation, Korea | Coronary Stenoses | 01/25 | 01/25 | | |
PROTECT-HBR, NCT04416581: Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy |
|
|
| Recruiting | 4 | 3100 | RoW | PPI, P-CAB 50 | Duk-Woo Park, MD | Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Myocardial Infarction | 09/26 | 12/27 | | |
NCT05648838: Evaluation of Safety and Efficacy of Pivot Balloon to Monitoring Acute RV Failure and Reduction of FTR |
|
|
| Completed | N/A | 7 | RoW | Pivot Balloon Catheter | Tau Pnu Medical Co., Ltd. | Functional Tricuspid Regurgitation | 01/23 | 01/23 | | |
| Recruiting | N/A | 7 | RoW | TIRA catheter, CA10 and ohter 3 models | Tau Pnu Medical Co., Ltd. | Hypertrophic Obstructive Cardiomyopathy | 04/26 | 08/26 | | |
| Recruiting | N/A | 2000 | RoW | Synergy XD stent or Synergy Megatron™ Stent | Jung-min Ahn, CardioVascular Research Foundation, Korea | Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases, Myocardial Ischemia, Coronary Disease | 12/26 | 12/31 | | |
PROVE-DM, NCT05579626: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus |
|
|
| Recruiting | N/A | 4000 | RoW | high-intensity statin arm, low-intensity statin plus ezetimibe | Seung-Whan Lee, M.D., Ph.D., Yuhan Corporation | Pre Diabetes, ASCVD | 12/27 | 12/27 | | |
| Jang, Byungik |
| Recruiting | 3 | 612 | Europe, Canada, US, RoW | ABX464, Obefazimod, Placebo | Abivax S.A. | Ulcerative Colitis | 03/25 | 04/25 | | |
| Recruiting | 3 | 778 | Europe, Canada, Japan, US, RoW | Mirikizumab, LY3074828 | Eli Lilly and Company | Crohn's Disease | 11/24 | 12/26 | | |
| Recruiting | 3 | 1050 | Europe, Canada, Japan, US, RoW | ABX464, Obefazimod, Placebo | Abivax S.A. | Ulcerative Colitis | 01/26 | 01/30 | | |
| Kim, Yu Seun |
PROUD, NCT05666804: Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy |
|
|
| Recruiting | 3 | 160 | RoW | Brolucizumab 6mg, Beovu | Novartis Pharmaceuticals | Macular Polypoidal Choroidal Vasculopathy (PCV) | 09/25 | 09/25 | | |
COSTAR Lung, NCT04655976 / 2020-003433-37: Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy |
|
|
| Active, not recruiting | 3 | 758 | Europe, Canada, Japan, US, RoW | Cobolimab, Dostarlimab, Docetaxel | GlaxoSmithKline | Lung Cancer, Non-Small Cell | 04/25 | 10/25 | | |
| Recruiting | 3 | 170 | Europe, Canada, Japan, US, RoW | Selpercatinib, LY3527723, LOXO-292, Placebo | Loxo Oncology, Inc., Eli Lilly and Company | Carcinoma, Non-Small-Cell Lung | 05/27 | 08/32 | | |
EAGLES, NCT03536780: Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment |
|
|
| Recruiting | 2 | 38 | RoW | Avelumab and Gemcitabine | Gachon University Gil Medical Center, Merck KGaA, Darmstadt, Germany, Chong Kun Dang Pharmaceutical Corp. | Leiomyosarcoma Metastatic | 12/21 | 12/22 | | |
| Recruiting | 2 | 100 | RoW | Tepotinib, MSC2156119J, EMD 1214063 | Chungbuk National University Hospital, Merck KGaA, Darmstadt, Germany | Solid Tumor, MET Exon 14 Skipping Mutation, MET Amplification | 02/23 | 08/24 | | |
NCT05326425: Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI. |
|
|
| Recruiting | 2 | 40 | RoW | lazertinib(YH25448) | Jin Hyoung Kang | Lung Neoplasms | 06/24 | 06/24 | | |
NCT05541822: To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation |
|
|
| Recruiting | 2 | 40 | US, RoW | ABN401 | Abion Inc | Advanced Solid Tumors | 04/25 | 08/25 | | |
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema |
|
|
| Recruiting | 2 | 150 | Japan, US, RoW | KHK4951, Aflibercept Injection | Kyowa Kirin Co., Ltd. | Diabetic Macular Edema (DME) | 11/25 | 12/25 | | |
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration |
|
|
| Recruiting | 2 | 180 | Japan, US, RoW | KHK4951, Aflibercept Injection | Kyowa Kirin Co., Ltd. | Neovascular Age-Related Macular Degeneration (nAMD) | 11/25 | 12/25 | | |
| Completed | 1/2 | 85 | Europe, US, RoW | 14 mg AFM24, 40 mg AFM24, 80 mg AFM24, 160 mg AFM24, 320 mg AFM24, 480 mg AFM24, 720 mg AFM24 | Affimed GmbH | Advanced Solid Tumor | 07/23 | 06/24 | | |
| Active, not recruiting | 1/2 | 856 | Europe, Canada, Japan, US, RoW | LOXO-292, Selpercatinib, LY3527723 | Loxo Oncology, Inc., Eli Lilly and Company | Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer, Any Solid Tumor | 02/25 | 02/26 | | |
|
|
|
|
|
|
|
| Recruiting | 1/2 | 148 | Europe, US, RoW | AFM24, Atezolizumab 840 MG in 14 ML Injection | Affimed GmbH, Affimed GmbH | Advanced Solid Tumor | 02/25 | 11/25 | | |
NCT05920135: First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI |
|
|
| Recruiting | 1/2 | 92 | US, RoW | BBT-207 | Bridge Biotherapeutics, Inc. | EGFR Mutant Advanced Non-Small Cell Lung Cancer | 08/26 | 08/28 | | |
NCT06322693: A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) |
|
|
| Recruiting | 1 | 475 | Europe, US, RoW | TSR-022, Nivolumab, TSR-042, TSR-033, Docetaxel, Pemetrexed, Cisplatin, Carboplatin | GlaxoSmithKline | Neoplasms | 08/25 | 02/27 | | |
NCT03284502: HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors |
|
|
| Active, not recruiting | 1 | 148 | RoW | HM95573, cobimetinib, HM95573, cetuximab | Hanmi Pharmaceutical Company Limited | Locally Advanced Solid Tumor, Metastatic Solid Tumor | 09/24 | 12/24 | | |
| Recruiting | 1 | 447 | Europe, US, RoW | TSR-022, Nivolumab, TSR-042, TSR-033, Docetaxel, Pemetrexed, Cisplatin, Carboplatin | Tesaro, Inc. | Neoplasms | 04/25 | 04/27 | | |
|
|
|
| Recruiting | N/A | 396 | RoW | Home-based care | Seoul National University Hospital, Chung-Ang University Hosptial, Chung-Ang University College of Medicine, DongGuk University, Kyung Hee University Hospital, Bundang CHA Hospital, Seoul National University Bundang Hospital | Malignant Neoplasm, Home Care Services, Quality of LIfe, Unplanned Hospitalization | 12/26 | 12/26 | | |
NCT05039333: Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical Navigation |
|
|
| Not yet recruiting | N/A | 36 | RoW | RUS(TM) software : surgical navigation | Hutom Corp | Surgery, Gastric Cancer | 12/21 | 06/22 | | |
| Chang, Min Ho |
| Not yet recruiting | N/A | 22 | RoW | repetitive transcranial magnetic stimulation | Min Cheol Chang | Diabetic Peripheral Neuropathic Pain | 05/21 | 06/21 | | |
| Not yet recruiting | N/A | 32 | RoW | Injection with triamcinolone acetonide, bupivacaine, and normal saline | Min Cheol Chang | Cervical Facet Joint Pain | 09/21 | 10/21 | | |
NCT04822753: Platelet Rich Plasma (PRP) for Facet Mediated Lumbar Low Back Pain |
|
|
| Recruiting | N/A | 170 | US | Platelet Rich Plasma injection to the lumbar facet joint | Womack Army Medical Center, Uniformed Services University of the Health Sciences, The Geneva Foundation | Facet Joint Pain; Low Back Pain | 09/24 | 09/25 | | |
| Shon, Oog Jin |
NCT03412864: A Post Marketing Surveillance Study of INVOSSA K Inj. |
|
|
| Active, not recruiting | N/A | 3000 | RoW | | Kolon Life Science | Osteoarthritis | 07/23 | 07/23 | | |
| Contact, Site Public |
| Completed | 4 | 50 | RoW | ADVATE | Baxalta now part of Shire, Takeda Development Center Americas, Inc. | Hemophilia A | 02/23 | 02/23 | | |
SWITCH, NCT04718779: A Study of Enzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction Therapy |
|
|
| Completed | 4 | 4 | US | Digital Engagement Application (GD App), No Intervention | Takeda | Gaucher Disease | 02/23 | 02/23 | | |
| Active, not recruiting | 4 | 200 | US | CDPATH™, PROSPECT, Blood Draw | Takeda | Crohn's Disease | 10/25 | 06/26 | | |
| Recruiting | 4 | 80 | RoW | Leuprorelin Acetate Depot 3M, Leuprolide acetate Depot 3M | Takeda, Takeda | Central Precocious Puberty | 05/25 | 05/25 | | |
